428 related articles for article (PubMed ID: 12824052)
21. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.
Archer SL; Souil E; Dinh-Xuan AT; Schremmer B; Mercier JC; El Yaagoubi A; Nguyen-Huu L; Reeve HL; Hampl V
J Clin Invest; 1998 Jun; 101(11):2319-30. PubMed ID: 9616203
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effects of pimozide, an antipsychotic drug, on voltage-gated K
Seo MS; An JR; Heo R; Kang M; Park S; Mun SY; Park H; Han ET; Han JH; Chun W; Song G; Park WS
Drug Chem Toxicol; 2023 Mar; 46(2):271-280. PubMed ID: 35317682
[TBL] [Abstract][Full Text] [Related]
23. Kv1.1 channels of dorsal root ganglion neurons are inhibited by n-butyl-p-aminobenzoate, a promising anesthetic for the treatment of chronic pain.
Beekwilder JP; O'Leary ME; van den Broek LP; van Kempen GT; Ypey DL; van den Berg RJ
J Pharmacol Exp Ther; 2003 Feb; 304(2):531-8. PubMed ID: 12538804
[TBL] [Abstract][Full Text] [Related]
24. The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel.
Kang J; Chen XL; Rampe D
Biochem Biophys Res Commun; 2001 Aug; 286(3):499-504. PubMed ID: 11511086
[TBL] [Abstract][Full Text] [Related]
25. Members of the Kv1 and Kv2 voltage-dependent K(+) channel families regulate insulin secretion.
MacDonald PE; Ha XF; Wang J; Smukler SR; Sun AM; Gaisano HY; Salapatek AM; Backx PH; Wheeler MB
Mol Endocrinol; 2001 Aug; 15(8):1423-35. PubMed ID: 11463864
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Suessbrich H; Schönherr R; Heinemann SH; Attali B; Lang F; Busch AE
Br J Pharmacol; 1997 Mar; 120(5):968-74. PubMed ID: 9138706
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the endogenous IK currents in rat hippocampal neurons and cloned Kv2.1 channels in CHO cells.
Liu M; Gong B; Qi Z
Cell Biol Int; 2008 Dec; 32(12):1514-20. PubMed ID: 18801450
[TBL] [Abstract][Full Text] [Related]
28. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent.
Li Y; Gamper N; Shapiro MS
J Neurosci; 2004 Jun; 24(22):5079-90. PubMed ID: 15175377
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells.
Huang CW; Huang CC; Liu YC; Wu SN
Epilepsia; 2004 Jul; 45(7):729-36. PubMed ID: 15230694
[TBL] [Abstract][Full Text] [Related]
30. High affinity blockade of the HERG cardiac K(+) channel by the neuroleptic pimozide.
Kang J; Wang L; Cai F; Rampe D
Eur J Pharmacol; 2000 Mar; 392(3):137-40. PubMed ID: 10762666
[TBL] [Abstract][Full Text] [Related]
31. Transforming growth factor-alpha changes firing properties of developing neocortical GABAergic neurons by down-regulation of voltage-gated potassium currents.
Namba H; Takei N; Nawa H
Neuroscience; 2003; 122(3):637-46. PubMed ID: 14622907
[TBL] [Abstract][Full Text] [Related]
32. Molecular site of action of the antiarrhythmic drug propafenone at the voltage-operated potassium channel Kv2.1.
Madeja M; Leicher T; Friederich P; Punke MA; Haverkamp W; Musshoff U; Breithardt G; Speckmann EJ
Mol Pharmacol; 2003 Mar; 63(3):547-56. PubMed ID: 12606761
[TBL] [Abstract][Full Text] [Related]
33. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.
Main MJ; Cryan JE; Dupere JR; Cox B; Clare JJ; Burbidge SA
Mol Pharmacol; 2000 Aug; 58(2):253-62. PubMed ID: 10908292
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
[TBL] [Abstract][Full Text] [Related]
35. Galantamine blocks cloned Kv2.1, but not Kv1.5 potassium channels.
Zhang HX; Zhang W; Jin HW; Wang XL
Brain Res Mol Brain Res; 2004 Nov; 131(1-2):136-40. PubMed ID: 15530663
[TBL] [Abstract][Full Text] [Related]
36. Postnatal development of A-type and Kv1- and Kv2-mediated potassium channel currents in neocortical pyramidal neurons.
Guan D; Horton LR; Armstrong WE; Foehring RC
J Neurophysiol; 2011 Jun; 105(6):2976-88. PubMed ID: 21451062
[TBL] [Abstract][Full Text] [Related]
37. KCNA10: a novel ion channel functionally related to both voltage-gated potassium and CNG cation channels.
Lang R; Lee G; Liu W; Tian S; Rafi H; Orias M; Segal AS; Desir GV
Am J Physiol Renal Physiol; 2000 Jun; 278(6):F1013-21. PubMed ID: 10836990
[TBL] [Abstract][Full Text] [Related]
38. MinK-related peptide 2 modulates Kv2.1 and Kv3.1 potassium channels in mammalian brain.
McCrossan ZA; Lewis A; Panaghie G; Jordan PN; Christini DJ; Lerner DJ; Abbott GW
J Neurosci; 2003 Sep; 23(22):8077-91. PubMed ID: 12954870
[TBL] [Abstract][Full Text] [Related]
39. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons.
Shen QJ; Zhao YM; Cao DX; Wang XL
J Neurosci Res; 2009 Nov; 87(14):3153-60. PubMed ID: 19472219
[TBL] [Abstract][Full Text] [Related]
40. KChAP/Kvbeta1.2 interactions and their effects on cardiac Kv channel expression.
Kuryshev YA; Wible BA; Gudz TI; Ramirez AN; Brown AM
Am J Physiol Cell Physiol; 2001 Jul; 281(1):C290-9. PubMed ID: 11401852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
